More Subjects
INFLUENZA VACCINATION
NAME
INSTITUTION
Influenza vaccination
Vaccination is the most effective way to prevent a disease. Influenza disease impacts each year up to 10% of the population. The hostile effect of influenza has led to commendation for large use of vaccine. For instance the spread of influenza in the elderly is exceeded by that of infants. The manufactures agreed to increase the production of influenza vaccine in the US. This was agreed by the Centres for Disease control and prevention and the National Vaccine Advisory committee and others. It was recommended in the US that all children between 6 to 23 months be vaccinated and young infants too. It is approximated that each year about 26,000 people are killed by influenza while 200,000 people are hospitalised Influenza vaccination has various challenges including high vaccine cost. (Gregory A Poland, 2004)
High production cost of influenza vaccine.
For instance, in the US biologist need high costs of capital investments. The investments costs result from the research of vaccine and development and clinic trials. There was a change in the US Food and drug administration leading to the change of current process of manufacturing practices that required a lot of upgrade and high cost. (Gregory A Poland, 2004). Children are known to be the spreaders of influenza disease. In United States , children vaccination has been well researched and studied and therefore there is an association in decrease of sickness. There is huge capital requirement in upgrading the vaccine manufacturing industry.
However there are some other alternatives to the high cost of influenza vaccine. These include;
Government providing incentives to private industries that manufacture vaccines. This includes provision of subsidies which encourages upgrading of manufacturing plants and building of new manufacturing industries. The government awards substantial amounts to the manufacturing plants.
The disadvantage of government incentive is that it is more risk hostile than funding from private funders.
Working together with the US government to determine ways to reduce the cost of the US food and Drug administration. This will help in finding the solution towards decreasing the costs of upgrade of manufacturing plants.
Therefore according to me the solution to the high cost of vaccine is the offering of government incentives for private industries for manufacturing vaccines to the public health. Incentives are offered in form of subsidies and also includes mechanisms like tax break. These enhance building of new manufacturing industries and upgrade of already existing manufacturing industries.
The government allowing varying prices whereby the vaccines are sold to developing countries at a lower price and developed countries at high prices. This also improves the technology platform since government is involved in sharing the high technology cost through offering direct grants and incentives.in addition, participating in developing new platforms in technology by the federal that could provide incentives too. The government works closely with the manufacturing plants to determine ways to decrease the high cost of meeting the US Food and Drug Administration regulatory. (Gregory A Poland, 2004)
References
Poland,G., &Marcuse,E.(2004).Vaccine availability.Nature immunology,5(12), 1-4,from https://scholar.google.com/scholar?
Carrat,F.,Flahault.A.(2007).Vaccine,25(39-40),6852-6862
More Subjects
Join our mailing list
© All Rights Reserved 2024